National uniformity legislation for OTCs included in Senate/House FDA reform bills.
This article was originally published in The Tan Sheet
Executive Summary
FEDERAL PREEMPTION OVER STATE OTC DRUG LAWS would be instituted under Sen. Nancy Kassebaum's (R-Kan.) FDA reform legislation (S 1477) approved by the Senate Labor Committee on March 28. The preemption provision, intended to "provide for the uniformity of federal, state and local requirements respecting nonprescription drugs," was approved by the committee by a 10-6 vote during a markup of the bill.